Research_strapline

Are you an:

Don't let the labels put you off!
If you're not an investor, but you want to learn, you can select investor

×

Register for FundCalibre!

We just need to know
if you are an:

Don't let the labels put you off!
If you're not an investor, but you want to learn, you can select investor

×

1 November 2016

Japanese and Indian equities top the pile in October

The month of October saw Japanese and Indian equity funds dominate the top ten Elite Rated performers. Global markets have endured an extremely volatile year, but with uncertainty comes investment opportunities.

Japanese stocks have previously tended to outperform when both the dollar is rising against the yen and oil prices are falling, a trend that repeated itself under these conditions during October. Investing in India has become more of an attractive proposition for investors in recent years, with steps to standardise regulations and invest heavily in infrastructure key contributors, and the recently passed Goods & Services Tax bill effectively making India one unified common market. With China’s growth slowing, the world is looking to India to take up the reigns and this bill should certainly help.

Aberdeen Latin American Equity came out top of the Elite Funds, Man GLG Japan Core Alpha came in second and Schroder Tokyo in third place. Meanwhile, all three of our Elite Rated India funds made the top ten.

Top performing Elite funds during October 2016*

When it came to UK equities, Investec UK Special Situations was in first place and Schroder Recovery the runner-up, with Jupiter UK Special Situations in third place.

Top performing Elite UK equity funds during October 2016*



Where to next?



*Source: FE Analytics, Total returns in sterling, 1 Oct 2016 – 31 Oct 2016

©2016 FundCalibre Ltd. All Rights Reserved. The information, data, analyses, and opinions contained herein (1) include the proprietary information of FundCalibre, (2) may not be copied or redistributed without prior permission, (3) do not constitute investment advice offered by FundCalibre, (4) are provided solely for informational purposes and therefore are not an offer to buy or sell a security, and (5) are not warranted to be correct, complete, or accurate. FundCalibre, shall not be responsible for any trading decisions, damages, or other losses resulting from, or related to, this information, data, analyses, or opinions or their use.